| 000 | 01010 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515002253.0 | ||
| 264 | 0 | _c20060602 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a1024-5332 | ||
| 024 | 7 |
_a10.1080/10245330512331389773 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurnett, Alan K | |
| 245 | 0 | 0 |
_aThe treatment of AML: current status and novel approaches. _h[electronic resource] |
| 260 |
_bHematology (Amsterdam, Netherlands) _c2005 |
||
| 300 |
_a50-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xtherapy |
| 773 | 0 |
_tHematology (Amsterdam, Netherlands) _gvol. 10 Suppl 1 _gp. 50-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10245330512331389773 _zAvailable from publisher's website |
| 999 |
_c15819880 _d15819880 |
||